Tian Y - Search Results

1

Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling.

Zhang H, Tian Y, Shen J, Wang Y, Xu Y, Wang Y, Han Z, Li X. Zhang H, et al. Among authors: tian y. Int J Oncol. 2014 Aug;45(2):719-31. doi: 10.3892/ijo.2014.2482. Epub 2014 Jun 3. Int J Oncol. 2014. PMID: 24899407

2

Ectopic overexpression of COTE1 promotes cellular invasion of hepatocellular carcinoma.

Zhang H, Huang CJ, Tian Y, Wang YP, Han ZG, Li XC. Zhang H, et al. Among authors: tian y. Asian Pac J Cancer Prev. 2012;13(11):5799-804. doi: 10.7314/apjcp.2012.13.11.5799. Asian Pac J Cancer Prev. 2012. PMID: 23317259 Free article.

3

CDCA7L promotes hepatocellular carcinoma progression by regulating the cell cycle.

Tian Y, Huang C, Zhang H, Ni Q, Han S, Wang D, Han Z, Li X. Tian Y, et al. Int J Oncol. 2013 Dec;43(6):2082-90. doi: 10.3892/ijo.2013.2142. Epub 2013 Oct 17. Int J Oncol. 2013. PMID: 24141559

4

Latexin exhibits tumor suppressor potential in hepatocellular carcinoma.

Ni QF, Tian Y, Kong LL, Lu YT, Ding WZ, Kong LB. Ni QF, et al. Among authors: tian y. Oncol Rep. 2014 Mar;31(3):1364-72. doi: 10.3892/or.2014.2966. Epub 2014 Jan 8. Oncol Rep. 2014. PMID: 24399246

5

Remote ischemic preconditioning protects against liver ischemia-reperfusion injury via heme oxygenase-1-induced autophagy.

Wang Y, Shen J, Xiong X, Xu Y, Zhang H, Huang C, Tian Y, Jiao C, Wang X, Li X. Wang Y, et al. Among authors: tian y. PLoS One. 2014 Jun 10;9(6):e98834. doi: 10.1371/journal.pone.0098834. eCollection 2014. PLoS One. 2014. PMID: 24914543 Free PMC article.

6

Polyol pathway exacerbated ischemia/reperfusion-induced injury in steatotic liver.

Zhang C, Huang C, Tian Y, Li X. Zhang C, et al. Among authors: tian y. Oxid Med Cell Longev. 2014;2014:963629. doi: 10.1155/2014/963629. Epub 2014 May 21. Oxid Med Cell Longev. 2014. PMID: 24967007 Free PMC article.

7

Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.

Huang C, Tian Y, Peng R, Zhang C, Wang D, Han S, Jiao C, Wang X, Zhang H, Wang Y, Li X. Huang C, et al. Among authors: tian y. J Gastroenterol Hepatol. 2015 Feb;30(2):421-33. doi: 10.1111/jgh.12722. J Gastroenterol Hepatol. 2015. PMID: 25168293

8

CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1.

Lu Y, Zhou S, Cheng G, Ruan Y, Tian Y, Lv K, Han S, Zhou X. Lu Y, et al. Among authors: tian y. J Oncol. 2022 Aug 24;2022:1911592. doi: 10.1155/2022/1911592. eCollection 2022. J Oncol. 2022. PMID: 36059806 Free PMC article.

9

The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer.

Chang H, Wang J, Tian Y, Xu J, Gou X, Cheng J. Chang H, et al. Among authors: tian y. Oncol Rep. 2012 May;27(5):1353-9. doi: 10.3892/or.2012.1668. Epub 2012 Feb 1. Oncol Rep. 2012. PMID: 22307108

10

Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells.

Zhao Q, Tan BB, Li Y, Fan LQ, Yang PG, Tian Y. Zhao Q, et al. Among authors: tian y. Oncol Res. 2016;23(3):129-36. doi: 10.3727/096504015X14500513118029. Oncol Res. 2016. PMID: 26931435 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,161 results

Search Page

Filters